Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Background.Advancing age, chronic inflammation, oxidative damage, and disorders of lipid metabolism are positively linked to the late-life cognitive impairment. Serum biomarkers may be associated with the cognitive status in older men.Methods.440 old male subjects with different cognitive functions were recruited to investigate probable serum markers. Pearson Chi-Squared test, univariate analysis, and multivariate logistic regression analysis were performed to evaluate biomarkers which may be associated with cognitive status.Results.Levels of fundus atherosclerosis (AS) (P<0.001), age (P<0.001), serum biomarkers peroxidase (POD) (P=0.026) and interleukin-6 (IL-6) (P=0.001), serum levels of high-density lipoprotein cholesterol (HDL-C) (P<0.001), apolipoprotein A2 (ApoA2) (P=0.001), and ApoC2 (P=0.005) showed significant differences. Compared to group 3, ApoA1 in group 1 (OR = 1.30, 95% CI 1.01–1.67) and group 2 (OR = 1.47, 95% CI 1.11–1.94) were higher, while ApoA2 were lower (group 1: OR = 0.43, 95% CI 0.18–1.02; group 2: OR = 0.21, 95% CI 0.08–0.54) after adjusting for control variables.Conclusion.The results demonstrated that age, AS levels, POD, IL-6, HDL-C, ApoA2, and ApoC2 were significantly related to cognitive status. Moreover, ApoA1 and ApoA2 were independently associated with cognitive impairment and late-life dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cells harboring PSMC5 variants exhibit characteristics reminiscent of senescent or neurodegenerative cells, including impaired mitophagy47, type I IFN response48, abnormal apolipoproteins and/or cholesterol levels49,50, cognitive inflexibility51,52, impaired neuritogenesis53,54, and an imbalanced E/I ratio55,56.”
From Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies (2025) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · cited 1×
“The subjects for the study were divided into three groups according to MMSE scores: group 1 (28 ≤ MMSE≤ 30), group 2 (24≤MMSE≤ 27), and group 3 (MMSE ≤ 23).”
BackgroundInflammatory markers in population studies of aging
Singh, T., & Newman, A. B. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.11.002 · Cited by 863
Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review
Eichner, J. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.6.487 · Cited by 796 · cited 1×
“Apolipoproteins are important components of plasma lipoproteins which are synthesized in liver and have been proved to play a significant role in the lipid metabolism and the formation of lipoproteins [36].”
BackgroundLipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention
Munoz (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s6269 · Cited by 760
Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study
Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710
Inflammatory markers and cognition in well-functioning African-American and white elders
Yaffe, K., Lindquist, K., Penninx, B. W., Simonsick, E. M., Pahor, M., Kritchevsky, S., Launer, L., Kuller, L., Rubin, S., & Harris, T. (2003) · Neurology · doi:10.1212/01.wnl.0000073620.42047.d7 · Cited by 706 · cited 1×
“The subjects for the study were divided into three groups according to MMSE scores: group 1 (28 ≤ MMSE≤ 30), group 2 (24≤MMSE≤ 27), and group 3 (MMSE ≤ 23).”
BackgroundSerum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease
Notkola, I.-L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., & Nissinen, A. (1998) · Neuroepidemiology · doi:10.1159/000026149 · Cited by 669
Late-Life Depression, Mild Cognitive Impairment, and Dementia: Possible Continuum?
Panza, F., Frisardi, V., Capurso, C., D'Introno, A., Colacicco, A. M., Imbimbo, B. P., Santamato, A., Vendemiale, G., Seripa, D., Pilotto, A., et al. (2010) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181b0fa13 · Cited by 612
Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging
Weaver, J. D., Huang, M.-H., Albert, M., Harris, T., Rowe, J. W., & Seeman, T. E. (2002) · Neurology · doi:10.1212/wnl.59.3.371 · Cited by 536
Serum Lipoprotein Levels, Statin Use, and Cognitive Function in Older Women
Yaffe, K., Barrett-Connor, E., Lin, F., & Grady, D. (2002) · Archives of Neurology · doi:10.1001/archneur.59.3.378 · Cited by 439
Kuusisto, J., Koivisto, K., Mykkänen, L., Helkala, E.-L., Vanhanen, M., Hänninen, T., Kervinen, K., Kesäniemi, Y. A., Riekkinen, P. J., & Laakso, M. (1997) · BMJ · doi:10.1136/bmj.315.7115.1045 · Cited by 429
Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly
Buchman, A. S., Boyle, P. A., Wilson, R. S., Tang, Y., & Bennett, D. A. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318068de1d · Cited by 420 · cited 1×
“The subjects for the study were divided into three groups according to MMSE scores: group 1 (28 ≤ MMSE≤ 30), group 2 (24≤MMSE≤ 27), and group 3 (MMSE ≤ 23).”
BackgroundHigh total cholesterol levels in late life associated with a reduced risk of dementia
Mielke, M. M., Zandi, P. P., Sjögren, M., Gustafson, D., Östling, S., Steen, B., & Skoog, I. (2005) · Neurology · doi:10.1212/01.wnl.0000161870.78572.a5 · Cited by 411
Thambisetty, M., Simmons, A., Velayudhan, L., Hye, A., Campbell, J., Zhang, Y., Wahlund, L.-O., Westman, E., Kinsey, A., Güntert, A., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.78 · Cited by 405
Vellas, B., Coley, N., Ousset, P.-J., Berrut, G., Dartigues, J.-F., Dubois, B., Grandjean, H., Pasquier, F., Piette, F., Robert, P., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70206-5 · Cited by 398
Padurariu, M., Ciobica, A., Hritcu, L., Stoica, B., Bild, W., & Stefanescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.033 · Cited by 378 · cited 1×
“The subjects for the study were divided into three groups according to MMSE scores: group 1 (28 ≤ MMSE≤ 30), group 2 (24≤MMSE≤ 27), and group 3 (MMSE ≤ 23).”
BackgroundMicrovascular network alterations in the retina of patients with Alzheimer's disease
Cheung, C. Y., Ong, Y. T., Ikram, M. K., Ong, S. Y., Li, X., Hilal, S., Catindig, J. S., Venketasubramanian, N., Yap, P., Seow, D., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.06.009 · Cited by 315
Serum cholesterol changes after midlife and late-life cognition: Twenty-one-year follow-up study
Solomon, A., Kåreholt, I., Ngandu, T., Winblad, B., Nissinen, A., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2007) · Neurology · doi:10.1212/01.wnl.0000256368.57375.b7 · Cited by 311
Vural, H., Demirin, H., Kara, Y., Eren, I., & Delibas, N. (2010) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2010.02.002 · Cited by 235
Peripheral Oxidative Stress Biomarkers in Mild Cognitive Impairment and Alzheimer's Disease
Torres, L. L., Quaglio, N. B., de Souza, G. T., Garcia, R. T., Dati, L. M. M., Moreira, W. L., de Melo Loureiro, A. P., de souza-Talarico, J. N., Smid, J., Porto, C. S., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110284 · Cited by 234
Excessive Sleepiness is Predictive of Cognitive Decline in the Elderly
Jaussent, I., Bouyer, J., Ancelin, M.-L., Berr, C., Foubert-Samier, A., Ritchie, K., Ohayon, M. M., Besset, A., & Dauvilliers, Y. (2012) · Sleep · doi:10.5665/sleep.2070 · Cited by 231
Lloret, A., Badía, M.-C., Mora, N. J., Pallardó, F. V., Alonso, M.-D., & Viña, J. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1033 · Cited by 222
Nontraditional risk factors combine to predict Alzheimer disease and dementia
Song, X., Mitnitski, A., & Rockwood, K. (2011) · Neurology · doi:10.1212/wnl.0b013e318225c6bc · Cited by 220
Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease
Soares, H. D. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1070 · Cited by 218
Song, F., Poljak, A., Crawford, J., Kochan, N. A., Wen, W., Cameron, B., Lux, O., Brodaty, H., Mather, K., Smythe, G. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034078 · Cited by 214 · cited 6×
“A significant trend in reduction of the levels of ApoE from ε2 to ε4 carriers or from ε4 noncarriers and ε4 heterozygote carriers to ε4 homozygous individuals was observed among healthy centenarians and adults, MCI, AD, and age-matched controls [37, 46, 73, 77, 78].”
BackgroundResultInfluentialEvans, R. M., Emsley, C. L., Gao, S., Sahota, A., Hall, K. S., Farlow, M. R., & Hendrie, H. (2000) · Neurology · doi:10.1212/wnl.54.1.240 · Cited by 209
Lewis, T. L., Cao, D., Lu, H., Mans, R. A., Su, Y. R., Jungbauer, L., Linton, M. F., Fazio, S., LaDu, M. J., & Li, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127829 · Cited by 208
Lipid metabolism in cognitive decline and dementia
Panza, F., D'Introno, A., Colacicco, A. M., Capurso, C., Pichichero, G., Capurso, S. A., Capurso, A., & Solfrizzi, V. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.007 · Cited by 189
Mining biomarkers in human sera using proteomic tools
Zhang, R., Barker, L., Pinchev, D., Marshall, J., Rasamoelisolo, M., Smith, C., Kupchak, P., Kireeva, I., Ingratta, L., & Jackowski, G. (2004) · PROTEOMICS · doi:10.1002/pmic.200300495 · Cited by 184
HDL and cognition in neurodegenerative disorders
Hottman, D. A., Chernick, D., Cheng, S., Wang, Z., & Li, L. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.015 · Cited by 182
Interleukin-6 Covaries Inversely With Cognitive Performance Among Middle-Aged Community Volunteers
Marsland, A. L., Petersen, K. L., Sathanoori, R., Muldoon, M. F., Neumann, S. A., Ryan, C., Flory, J. D., & Manuck, S. B. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000238451.22174.92 · Cited by 179
The apoAI-CIII-AIV gene cluster
Groenendijk, M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00539-1 · Cited by 164
Dementia risk prediction in the population: are screening models accurate?
Stephan, B. C. M., Kurth, T., Matthews, F. E., Brayne, C., & Dufouil, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.54 · Cited by 160
Interleukin-6 Is Associated With Cognitive Function: The Northern Manhattan Study
Wright, C. B., Sacco, R. L., Rundek, T. R., Delman, J. B., Rabbani, L. E., & Elkind, M. S. V. (2006) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2005.08.009 · Cited by 159
Willems van Dijk, K., Rensen, P. C., Voshol, P. J., & Havekes, L. M. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200406000-00002 · Cited by 154
Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging
Gupta, V. B., Laws, S. M., Villemagne, V. L., Ames, D., Bush, A. I., Ellis, K. A., Lui, J. K., Masters, C., Rowe, C. C., Szoeke, C., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318211c352 · Cited by 149
Heringa, S. M., Bouvy, W. H., van den Berg, E., Moll, A. C., Kappelle, L. J., & Biessels, G. J. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.58 · Cited by 149
Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia
Puertas, M. C., Martínez-Martos, J. M., Cobo, M. P., Carrera, M. P., Mayas, M. D., & Ramírez-Expósito, M. J. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.05.019 · Cited by 140
Inflammatory markers and cognitive function in middle-aged adults: The Whitehall II study
Gimeno, D., Marmot, M. G., & Singh-Manoux, A. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.07.006 · Cited by 128
Systemic Inflammation Is Associated with MCI and Its Subtypes: The Sydney Memory and Aging Study
Trollor, J. N., Smith, E., Baune, B. T., Kochan, N. A., Campbell, L., Samaras, K., Crawford, J., Brodaty, H., & Sachdev, P. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000322092 · Cited by 124
Circulating interleukin‐6 concentration and cognitive decline in old age: the PROSPER study
Mooijaart, S. P., Sattar, N., Trompet, S., Lucke, J., Stott, D. J., Ford, I., Jukema, J. W., Westendorp, R. G. J., & de Craen, A. J. M. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12052 · Cited by 117
Long‐Term Systemic Inflammation and Cognitive Impairment in a Population‐Based Cohort
Wichmann, M. A., Cruickshanks, K. J., Carlsson, C. M., Chappell, R., Fischer, M. E., Klein, B. E. K., Klein, R., Tsai, M. Y., & Schubert, C. R. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12994 · Cited by 104
Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease
Taddei, K., Clarnette, R., E. Gandy, S., & Martins, R. N. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13394-8 · Cited by 98
Measurement of Apolipoprotein E (apoE) in Cerebrospinal Fluid
Hesse, C., Larsson, H. E., Fredman, P., Minthon, L., Andreasen, N., Davidsson, P., & Blennow, K. (2000) · Neurochemical Research · doi:10.1023/a:1007516210548 · Cited by 97
Lipid metabolism in long-lived families: the Leiden Longevity Study
On behalf of the project group and the Leiden Longevity Study (LLS) Group, Vaarhorst, A. A. M., Beekman, M., Suchiman, H. E. D., van Heemst, D., Houwing‐Duistermaat, J. J., Westendorp, R. G. J., Slagboom, P. E., & Heijmans, B. T. (2010) · AGE · doi:10.1007/s11357-010-9172-6 · Cited by 96
Kharrazi, H., Vaisi‐Raygani, A., Rahimi, Z., Tavilani, H., Aminian, M., & Pourmotabbed, T. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.05.001 · Cited by 95
Hypertension, cognitive decline, and dementia: an epidemiological perspective
Tzourio, C. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.1/ctzourio · Cited by 94
Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease
Scacchi, R., Gambina, G., Ruggeri, M., Martini, M. C., Ferrari, G., Silvestri, M., Schiavon, R., & Corbo, R. M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00889-1 · Cited by 83 · cited 1×
“The subjects for the study were divided into three groups according to MMSE scores: group 1 (28 ≤ MMSE≤ 30), group 2 (24≤MMSE≤ 27), and group 3 (MMSE ≤ 23).”
BackgroundComijs, H. C., Dik, M. G., Deeg, D. J. H., & Jonker, C. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000076346 · Cited by 81
Apolipoprotein E, an important player in longevity and age-related diseases
Ang, L. S., Cruz, R. P., Hendel, A., & Granville, D. J. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.03.010 · Cited by 76
Siest, G., Bertrand, P., Qin, B., Herbeth, B., Serot, J.-M., Masana, L., Ribalta, J., Passmore, A. P., Evans, A., Ferrari, M., et al. (2000) · cclm · doi:10.1515/cclm.2000.102 · Cited by 74
Increased apolipoprotein B serum concentration in Alzheimer's disease
Caramelli, P., Nitrini, R., Maranhão, R., Lourenço, A. C. G., Damasceno, M. C., Vinagre, C., & Caramelli, B. (1999) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00724.x · Cited by 74
Interleukin 6 Plasma Concentration Associates with Cognitive Decline: The Northern Manhattan Study
Economos, A., Wright, C. B., Moon, Y. P., Rundek, T., Rabbani, L., Paik, M. C., Sacco, R. L., & Elkind, M. S. V. (2013) · Neuroepidemiology · doi:10.1159/000343276 · Cited by 71
Kawano, M., Kawakami, M., Otsuka, M., Yashima, H., Yaginuma, T., & Ueki, A. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06115-t · Cited by 68 · cited 2×
“The result was in accordance with previous studies [40].”
BackgroundResultDarreh-Shori, T., Forsberg, A., Modiri, N., Andreasen, N., Blennow, K., Kamil, C., Ahmed, H., Almkvist, O., Långström, B., & Nordberg, A. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.028 · Cited by 64
Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study
Slooter, A. J. C., de Knijff, P., Hofman, A., Cruts, M., Breteler, M. M. B., Broeckhoven, C. V., Havekes, L. M., & van Duijn, C. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00339-5 · Cited by 63
Serum High-Density Lipoprotein Cholesterol Levels and Mortality in Frail, Community-Living Elderly
Landi, F., Russo, A., Pahor, M., Capoluongo, E., Liperoti, R., Cesari, M., Bernabei, R., & Onder, G. (2008) · Gerontology · doi:10.1159/000111381 · Cited by 61
Darreh‐Shori, T., Modiri, N., Blennow, K., Baza, S., Kamil, C., Ahmed, H., Andreasen, N., & Nordberg, A. K. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.07.015 · Cited by 59
Oxidative Imbalance in Different Neurodegenerative Diseases with Memory Impairment
Gironi, M., Bianchi, A., Russo, A., Alberoni, M., Ceresa, L., Angelini, A., Cursano, C., Mariani, E., Nemni, R., Kullmann, C., et al. (2010) · Neurodegenerative Diseases · doi:10.1159/000319452 · Cited by 53
Panza, F., Solfrizzi, V., Colacicco, A. M., Basile, A. M., D’Introno, A., Capurso, C., Sabba, M., Capurso, S., & Capurso, A. (2003) · NeuroReport · doi:10.1097/00001756-200303240-00016 · Cited by 50
Decreased Serum Lipids in Patients with Probable Alzheimer´s Disease
Lepara, O., Valjevac, A., Alajbegović, A., Zaćiragić, A., & Nakaš-Ićindić, E. (2009) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2009.2809 · Cited by 50
Meta-Analysis of Peripheral Blood Apolipoprotein E Levels in Alzheimer’s Disease
Wang, C., Yu, J.-T., Wang, H.-F., Jiang, T., Tan, C.-C., Meng, X.-F., Soares, H. D., & Tan, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089041 · Cited by 48
Leoutsakos, J.-M. S., Han, D., Mielke, M. M., Forrester, S. N., Tschanz, J. T., Corcoran, C. D., Green, R. C., Norton, M. C., Welsh-Bohmer, K. A., & Lyketsos, C. G. (2012) · International Psychogeriatrics · doi:10.1017/s104161021200049x · Cited by 46
Piacentini, S., Polimanti, R. A., Squitti, R., Mariani, S., Migliore, S., Vernieri, F., Rossini, P. M., Manfellotto, D., & Fuciarelli, M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.11.005 · Cited by 39
Attempted decomposition of age-related influences on two tests of reasoning.
Salthouse, T. A. (2001) · Psychology and Aging · doi:10.1037//0882-7974.16.2.251 · Cited by 38
Serum lipid levels in patients with Alzheimer's disease.
Presečki, P., Mück‐Šeler, D., Mimica, N., Pivac, N., Mustapić, M., Stipčević, T., & Šmalc, V. F. (2011) · PubMed · Cited by 38
GSTM1 null genotype as risk factor for late-onset Alzheimer's disease in Italian patients
Piacentini, S., Polimanti, R. A., Squitti, R., Ventriglia, M., Cassetta, E., Vernieri, F., Rossini, P. M., Manfellotto, D., & Fuciarelli, M. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.01.026 · Cited by 36
Talarowska, M. E., Gałecki, P., Maes, M. H. J., Bobińska, K., & Kowalczyk, E. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0788-z · Cited by 35
Zito, G., Polimanti, R. A., Panetta, V., Ventriglia, M., Salustri, C., Siotto, M., Moffa, F., Altamura, C., Vernieri, F., Lupoi, D., et al. (2012) · Rejuvenation Research · doi:10.1089/rej.2012.1383 · Cited by 27
Guimarães, F. C., Amorim, P. R. D. S., dos Reis, F. F., Teixeira, R. B., de Oliveira, W. C., Moura, T. A. D. S., de Assis, C. L., Palotás, A., & Lima, L. M. (2014) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000366413 · Cited by 22
Formiga, F., Ferrer, A., Chivite, D., Pintó, X., Badia, T., Padrós, G., & Pujol, R. (2012) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0018-z · Cited by 22
Genetic Association Study between Senile Dementia of Alzheimer’s Type and APOE/C1/C2 Gene Cluster
Kamino, K., Yoshiiwa, A., Nishiwaki, Y., Nagano, K., Yamamoto, H., Kobayashi, T., Nonomura, Y., Yoneda, H., Sakai, T., Imagawa, M., et al. (1996) · Gerontology · doi:10.1159/000213820 · Cited by 22
Formiga, F., Ferrer, A., Chivite, D., Pintó, X., Cuerpo, S., & Pujol, R. (2011) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2010.00681.x · Cited by 21
Plasma Levels of Apolipoprotein E and Cognitive Function in Old Age
MOOIJAART, S. P., VAN VLIET, P., VAN HEEMST, D., RENSEN, P. C. N., BERBÉE, J. F. P., JOLLES, J., DE CRAEN, A. J. M., & WESTENDORP, R. G. J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1395.013 · Cited by 21
Peripheral inflammatory markers in amnestic mild cognitive impairment
Karim, S., Hopkins, S., Purandare, N. B., Crowther, J., Morris, J., Tyrrell, P. J., & Burns, A. S. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3988 · Cited by 20
Morrow, L., Snitz, B. E., Rodriquez, E. G., Huber, K., & Saxton, J. A. (2009) · Family Practice · doi:10.1093/fampra/cmp047 · Cited by 20
Peters, R., Beckett, N. S., Forette, F., Tuomilehto, J., Ritchie, C. W., Walton, I., Waldman, A. D., Clarke, R., Poulter, R., FLETCHER, A. E., et al. (2009) · International Psychogeriatrics · doi:10.1017/s1041610208008302 · Cited by 19
Apolipoprotein E as vascular risk factor in neurodegenerative dementia.
Folin, M., Baiguera, S., Conconi, M. T., Liddo, R. D., Carlo, E. D., Parnigotto, P. P., & Nussdorfer, G. G. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.14.4.609 · Cited by 18
Tukiainen, T., Jylänki, P., Mäkinen, V., Gröhn, O. H. J., Hallikainen, M., Soininen, H. S., Kivipelto, M., Kaski, K. K., Groop, P., Savolainen, M. J., et al. (2011) · The journal of nutrition health & aging · doi:10.1007/s12603-011-0341-9 · Cited by 18
Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.668 · Cited by 10 · cited 1×
“The subjects for the study were divided into three groups according to MMSE scores: group 1 (28 ≤ MMSE≤ 30), group 2 (24≤MMSE≤ 27), and group 3 (MMSE ≤ 23).”
Background
Research works printed but not linked: 1
- 52. Q. W. Ruan, Z. W. Yu, C. Ma et al., "Age-related differences in co-morbidity number, fudus atherosclerosis level and the serum values of GSH-Px, Hs-CRP and HDL-C in elderly Chinese patients, " Journal of Aging Research & Clinical Practice, In press.
Cited by
Svensson, T., Sawada, N., Mimura, M., Nozaki, S., Shikimoto, R., & Tsugane, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0336-y · Cited by 88
VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction
Usui, N., Iwata, K., Miyachi, T., Takagai, S., Wakusawa, K., Nara, T., Tsuchiya, K. J., Matsumoto, K., Kurita, D., Kameno, Y., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102917 · Cited by 48
Zhao, B., Shang, S., Li, P., Chen, C., Dang, L., Jiang, Y., Wang, J., Huo, K., Deng, M., Wang, J., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-018-0956-5 · Cited by 47
Effects of Plasma Lipids and Statins on Cognitive Function
Li, R., Wang, T., Lyu, P., Liu, Y., Chen, W., Fan, M., & Xu, J. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.225062 · Cited by 40
Proteomic Profiling of Seminal Plasma Proteins in Varicocele Patients
Selvam, M. K. P., & Agarwal, A. K. (2019) · The World Journal of Men s Health · doi:10.5534/wjmh.180118 · Cited by 37
Metadata
- Authors
- Ma, C., Li, J., Bao, Z., Ruan, Q., & Yu, Z.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Ruan, Qingwei
- Yu, Zhuowei
- Venue
- BioMed Research International
- Publisher
- Hindawi Limited
- Published
- 2015
- Volume
- 2015
- Pages
- 1-10
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4670907
- OpenAlex
- W2173974781
- Cited by
- 46
- References
- 81
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 7 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 3 · 2019: 6 · 2018: 4 · 2017: 8 · 2016: 1
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Shanghai Key Laboratory of Clinical Geriatric Medicine Subject Construction (13dz2260700, SHDC12014221)
- Shanghai Hospital Development Center (13dz2260700, SHDC12014221)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- apolipoprotein A-I, apolipoprotein A-II, apolipoprotein C2, serum biomarkers, cognitive impairment, dementia, older men, late-life cognitive decline, interleukin-6, peroxidase, HDL cholesterol, lipid metabolism
- MeSH terms
- Aged, Aged, 80 and over, Cognition, Cognition Disorders, Humans, Lipids, Lipoproteins, HDL, Male, Biomarkers, Interleukin-6, Apolipoprotein A-I, Apolipoprotein A-II, Serum, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.